ChatGPT. How closely should we be watching?
Businesspeople Sitting in Booths at a Big Creative Agency
© Klaus Vedfelt / Getty Images
    alt txt

    properties.trackTitle

    properties.trackSubtitle

    Could generative AI models such as ChatGPT eventually alter the science and art of risk selection? The answer is yes, according to Munich Re’s Dr. Tim Meagher.

    In this article, recently published in the Journal of Insurance Medicine, Dr. Meagher predicts several likely impacts on insurance medicine, including improved mortality through better disease detection and treatment, the arrival of novel predictive associations, and perhaps a redefinition of the notion of health. He also cautions that not all issues with AI in the medical sphere have been solved, which warrants a close watch as this technology unfolds.   

    Contact the Author
    Tim Meagher
    Dr. Tim Meagher
    Vice President & Medical Director
    Munich Re, Canada (Life)

    This may interest you